JP2002161074A5 - - Google Patents

Download PDF

Info

Publication number
JP2002161074A5
JP2002161074A5 JP2001255372A JP2001255372A JP2002161074A5 JP 2002161074 A5 JP2002161074 A5 JP 2002161074A5 JP 2001255372 A JP2001255372 A JP 2001255372A JP 2001255372 A JP2001255372 A JP 2001255372A JP 2002161074 A5 JP2002161074 A5 JP 2002161074A5
Authority
JP
Japan
Prior art keywords
neuraminidase
compound
label
sample
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001255372A
Other languages
English (en)
Japanese (ja)
Other versions
JP4234917B2 (ja
JP2002161074A (ja
Filing date
Publication date
Priority claimed from US08/476,946 external-priority patent/US5866601A/en
Application filed filed Critical
Publication of JP2002161074A publication Critical patent/JP2002161074A/ja
Publication of JP2002161074A5 publication Critical patent/JP2002161074A5/ja
Application granted granted Critical
Publication of JP4234917B2 publication Critical patent/JP4234917B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2001255372A 1995-02-27 2001-08-24 ウイルスまたは細菌ノイラミニダーゼの新規な選択的インヒビター Expired - Lifetime JP4234917B2 (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US39524595A 1995-02-27 1995-02-27
US08/476,946 US5866601A (en) 1995-02-27 1995-06-06 Carbocyclic compounds
US58056795A 1995-12-29 1995-12-29
US08/580,567 1995-12-29
US08/476,946 1995-12-29
US08/395,245 1995-12-29

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP52644296A Division JP3300365B2 (ja) 1995-02-27 1996-02-26 ウイルスまたは細菌ノイラミニダーゼの新規な選択的インヒビター

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2005207906A Division JP2006036770A (ja) 1995-02-27 2005-07-15 ウイルスまたは細菌ノイラミニダーゼの新規な選択的インヒビター
JP2008082197A Division JP2008273948A (ja) 1995-02-27 2008-03-26 ウイルスまたは細菌ノイラミニダーゼの新規な選択的インヒビター

Publications (3)

Publication Number Publication Date
JP2002161074A JP2002161074A (ja) 2002-06-04
JP2002161074A5 true JP2002161074A5 (enExample) 2005-10-27
JP4234917B2 JP4234917B2 (ja) 2009-03-04

Family

ID=27410155

Family Applications (3)

Application Number Title Priority Date Filing Date
JP52644296A Expired - Lifetime JP3300365B2 (ja) 1995-02-27 1996-02-26 ウイルスまたは細菌ノイラミニダーゼの新規な選択的インヒビター
JP2001255372A Expired - Lifetime JP4234917B2 (ja) 1995-02-27 2001-08-24 ウイルスまたは細菌ノイラミニダーゼの新規な選択的インヒビター
JP2005207906A Withdrawn JP2006036770A (ja) 1995-02-27 2005-07-15 ウイルスまたは細菌ノイラミニダーゼの新規な選択的インヒビター

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP52644296A Expired - Lifetime JP3300365B2 (ja) 1995-02-27 1996-02-26 ウイルスまたは細菌ノイラミニダーゼの新規な選択的インヒビター

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2005207906A Withdrawn JP2006036770A (ja) 1995-02-27 2005-07-15 ウイルスまたは細菌ノイラミニダーゼの新規な選択的インヒビター

Country Status (26)

Country Link
US (3) US5952375A (enExample)
EP (1) EP0759917B1 (enExample)
JP (3) JP3300365B2 (enExample)
KR (1) KR100447096B1 (enExample)
CN (2) CN100409844C (enExample)
AT (2) ATE305453T1 (enExample)
AU (1) AU720933B2 (enExample)
BR (2) BR9607098B8 (enExample)
CZ (1) CZ297945B6 (enExample)
DE (4) DE759917T1 (enExample)
DK (1) DK0759917T3 (enExample)
ES (2) ES2118674T3 (enExample)
GR (1) GR3033914T3 (enExample)
HU (1) HU228450B1 (enExample)
LU (1) LU90991I2 (enExample)
MX (1) MX9706496A (enExample)
NL (1) NL300105I2 (enExample)
NO (1) NO318455B1 (enExample)
NZ (1) NZ306625A (enExample)
PL (1) PL194173B1 (enExample)
PT (1) PT759917E (enExample)
RU (1) RU2181357C2 (enExample)
SG (1) SG45864A1 (enExample)
SI (1) SI9620042A (enExample)
UA (1) UA56128C2 (enExample)
WO (1) WO1996026933A1 (enExample)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI9620042A (sl) * 1995-02-27 1998-12-31 Gilead Sciences, Inc. Novi selektivni inhibitorji virusnih ali bakterijskih neuraminidaz
US5714509A (en) * 1995-05-03 1998-02-03 The University Of Alabama Inhibitors of bacterial sialidase and methods of making and using the same
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
US6093816A (en) 1996-06-27 2000-07-25 Isis Pharmaceuticals, Inc. Cationic lipids
US5859284A (en) * 1996-08-23 1999-01-12 Gilead Sciences, Inc. Preparation of carbocyclic compounds
US6518438B2 (en) 1996-08-23 2003-02-11 Gilead Sciences, Inc. Preparation of cyclohexene carboxylate derivatives
JP3622983B2 (ja) * 1996-08-23 2005-02-23 ギリアード サイエンシーズ， インコーポレイテッド シクロヘキセンカルボキシレート誘導体の調製
KR20000052702A (ko) * 1996-10-21 2000-08-25 헨슬레이 맥스 디. 피페리딘 화합물
US5994377A (en) 1996-10-21 1999-11-30 Gilead Sciences, Inc. Piperidine compounds
TR199901081T2 (xx) * 1996-11-14 1999-08-23 Biota Scientific Management Pty.Ltd. Y�ntem ve bu y�ntemde kullan�lan yeni bile�imler.
US6020344A (en) * 1997-08-01 2000-02-01 University Of Florida Enzyme inhibitors and methods of use
US5886213A (en) * 1997-08-22 1999-03-23 Gilead Sciences, Inc. Preparation of carbocyclic compounds
US20040053999A1 (en) * 1997-09-17 2004-03-18 Bischofberger Norbert W. Novel compounds and methods for synthesis and therapy
JP2001516739A (ja) * 1997-09-17 2001-10-02 ギリアード サイエンシーズ， インコーポレイテッド ６員環を含む化合物、それらの調製プロセス、および医薬としてのそれらの使用
TW480247B (en) * 1997-12-12 2002-03-21 Gilead Sciences Inc Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same
AU2200199A (en) * 1997-12-17 1999-07-19 Biocryst Pharmaceuticals, Inc. Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
US6518305B1 (en) 1998-04-23 2003-02-11 Abbott Laboratories Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
HUP0101224A3 (en) * 1998-04-23 2002-12-28 Abbott Lab Pyrrolidine derivatives as inhibitors of neuraminidases and pharmaceutical compositions containing them
US6455571B1 (en) 1998-04-23 2002-09-24 Abbott Laboratories Inhibitors of neuraminidases
DK0957078T3 (da) * 1998-05-13 2002-04-02 Hoffmann La Roche Fremgangsmåde til fremstilling af shikimisyre og derivater deraf
AU1476900A (en) * 1998-11-13 2000-06-05 Gilead Sciences, Inc. 1,4,5,6-tetrahydro-pyridazine derivatives, their preparation and their use as neuraminidase inhibitors
AUPP913999A0 (en) * 1999-03-12 1999-04-01 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
EP1059283B1 (en) 1999-06-11 2003-05-28 F. Hoffmann-La Roche Ag Process for preparing neuraminidase inhibitor ro-64-0796
DE19930177B4 (de) 1999-06-30 2007-02-08 Nikolai Vladimirovich Bovin Intermolekular assoziierende Verbindungen und deren Verwendung
US6593314B1 (en) 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
BR0010525A (pt) * 1999-10-19 2002-11-26 Abbott Lab cido 1-ciclo-hexeno-1-carboxìlico e 1-ciclo-hexeno-1carboxilatos como inibidores de neuraminidase
US6627396B1 (en) * 1999-10-28 2003-09-30 The Regents Of The University Of California Influenza sensor
JP2001131144A (ja) 1999-11-02 2001-05-15 Sagami Chem Res Center ７−アザビシクロ［４．１．０］ヘプト−３−エン−３−カルボン酸エステル類の製造方法
US6462226B1 (en) 1999-12-03 2002-10-08 Hoffmann-La Roche Inc. Process for the preparation of 4,5-diamino shikimic acid derivatives
WO2001047906A1 (en) * 1999-12-27 2001-07-05 Sagami Chemical Research Center Process for the production of 5-oxy-7-oxabicyclo-[4.1.0]hept-3-e ne-3-carboxylic acid esters
US8642051B2 (en) * 2000-03-21 2014-02-04 Suzanne Jaffe Stillman Method of hydration; infusion packet system(s), support member(s), delivery system(s), and method(s); with business model(s) and Method(s)
AU2001252578A1 (en) * 2000-04-25 2001-11-07 Sankyo Company Limited Preventives for influenza
GB0015324D0 (en) * 2000-06-22 2000-08-16 Biota Scient Management Medicaments
MXPA02012583A (es) 2000-06-27 2003-04-10 Hoffmann La Roche Metodo para preparacion de una composicion.
AUPR001000A0 (en) 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
WO2002092555A1 (en) * 2001-05-11 2002-11-21 Sankyo Company, Limited Sialic acid derivatives
US6964784B2 (en) * 2002-03-07 2005-11-15 Optigenex, Inc. Method of preparation and composition of a water soluble extract of the bioactive component of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals
RU2220739C1 (ru) * 2002-08-30 2004-01-10 Гапонюк Петр Яковлевич Интраназальное средство
US7807174B2 (en) * 2002-11-22 2010-10-05 Nexbio, Inc. Class of therapeutic protein based molecules
US7122684B2 (en) 2003-03-13 2006-10-17 Roche Colorado Corporation Process for preparing 1,2-diamino compounds
ATE496056T1 (de) 2003-06-16 2011-02-15 Acad Of Science Czech Republic Pyrimidinverbindungen mit phosphonatgruppen als antivirale nucleotidanaloga
WO2007053792A2 (en) * 2005-11-05 2007-05-10 Amplyx Pharmaceuticals, Inc. Improving the pharmacokinetics of protease inhibitors and other drugs
WO2007060681A1 (en) * 2005-11-25 2007-05-31 Hetero Drugs Limited Improved process for oseltamivir phosphate
KR100819759B1 (ko) 2005-12-01 2008-04-07 (주)파인켐 아자이드 화합물의 폭발성을 제거한 공정을 이용한 1,2-다이아미노 화합물 또는 이의 부가염 제조 방법
KR20080085061A (ko) 2005-12-28 2008-09-22 에프. 호프만-라 로슈 아게 타미플루 합성에서의 에폭사이드 중간체
WO2007097325A1 (ja) * 2006-02-20 2007-08-30 Chugai Seiyaku Kabushiki Kaisha リン酸オセルタミビル含有医薬組成物
US20080063722A1 (en) * 2006-09-08 2008-03-13 Advanced Inhalation Research, Inc. Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
US20080306098A1 (en) * 2006-11-06 2008-12-11 Mutz Mitchell W Pharmacokinetics of protease inhibitors and other drugs
US8227425B2 (en) 2007-01-23 2012-07-24 Therapicon Srl Antiviral compounds
US20080194801A1 (en) * 2007-02-14 2008-08-14 Swanson Basil I Robust multidentate ligands for diagnosis and anti-viral drugs for influenza and related viruses
US8435769B2 (en) 2007-04-13 2013-05-07 Monsanto Technology Llc Use of glyphosate to produce shikimic acid in microorganisms
US20090054334A1 (en) * 2007-05-23 2009-02-26 Mutz Mitchell W Combinatorial improvement of bifunctional drug properties
CN101883569B (zh) * 2007-08-31 2013-08-21 梁启铭 具有抗流感活性之含奥司他伟膦酸酯同系物的合成
EP2201123B1 (en) 2007-10-16 2012-01-18 Monsanto Technology, LLC Processes for recovering shikimic acid
WO2009055042A1 (en) * 2007-10-24 2009-04-30 Amplyx Pharmaceuticals, Inc. Enhancing the efficacy of anti-infective therapeutics
WO2009078813A1 (en) * 2007-12-19 2009-06-25 Nanyang Technological University Method of forming oseltamivir and derivatives thereof
US8334319B2 (en) * 2008-01-04 2012-12-18 Roche Palo Alto Llc Polymorphic forms of oseltamivir phosphate
US20100081713A1 (en) * 2008-03-19 2010-04-01 CombinatoRx, (Singapore) Pte. Ltd. Compositions and methods for treating viral infections
EP2276479B1 (en) 2008-04-15 2014-07-02 SineVir Therapeutics LLC Prodrugs of neuraminidase inhibitors
TWI491416B (zh) 2008-12-24 2015-07-11 Daiichi Sankyo Co Ltd 吸入用乾燥粉末醫藥組成物
CN101486664B (zh) * 2008-12-31 2013-09-04 北京大学深圳研究生院 用作流感病毒神经氨酸酶抑制剂的多取代五元环小分子化合物
EA201101564A1 (ru) 2009-05-15 2012-07-30 Редкс Фарма Лимитед Редокс производные лекарственных средств
WO2011021223A2 (en) * 2009-08-19 2011-02-24 Msn Laboratories Limited Novel salts of ethyl (3r, 4s, 5r)-4,5-imino-3-(l-ethylpropoxy)-1- cvclohexene-1-carboxylate and its use
WO2011059994A2 (en) * 2009-11-11 2011-05-19 3M Innovative Properties Company Polymeric compositions and method of making and articles thereof
IT1396620B1 (it) 2009-11-25 2012-12-14 Therapicon Srl Analoghi chimerici
EA201300142A1 (ru) 2010-07-16 2013-08-30 Гриндекс, Джоинт Сток Кампани Производные 1,4-дигидропиридина, обладающие противовирусной эффективностью
AT510585B1 (de) 2010-11-18 2012-05-15 Apeptico Forschung & Entwicklung Gmbh Zusammensetzung umfassend ein peptid und ein hemmstoff der viralen neuraminidase
KR101369584B1 (ko) 2011-04-19 2014-03-06 일양약품주식회사 페닐-이속사졸 유도체 및 그의 제조방법
EP2578218A1 (en) 2011-10-06 2013-04-10 Grindeks, A Joint Stock Company Antiviral efficacy of disodium 2,6-dimethyl-1,4-dihydropyridine-3,5-bis(carbonyloxyacetate) and its derivatives
DE102011117128A1 (de) 2011-10-28 2013-05-02 Christian-Albrechts-Universität Zu Kiel Verbindungen zur Therapie der Influenza
RU2469020C1 (ru) * 2011-11-08 2012-12-10 Александр Васильевич Иващенко (3r,4r,5s)-5-амино-4-ациламино-3-(1-этил-пропокси)-циклогекс-1-ен-карбоновые кислоты, их эфиры и способ применения
RU2489422C1 (ru) * 2012-05-12 2013-08-10 Александр Васильевич Иващенко Фторзамещенные (3r,4r,5s)-5-гуанидино-4-ациламино-3-(пентан-3-илокси)циклогексен-1-карбоновые кислоты, их эфиры и способ применения
RU2521593C1 (ru) * 2013-02-27 2014-06-27 Общество с ограниченной ответственностью "Интеллектуальный Диалог" Моно и дифторзамещенные этил (3r,4r,5s)-5-азидо-4-ацетиламино-3-(1-этилпропокси)-циклогексен-1-карбоксилаты, способ получения и применения
JP6453050B2 (ja) * 2013-11-15 2019-01-16 国立大学法人富山大学 ２−デオキシ−２，３−ジデヒドロシアル酸誘導体およびその製造法
CN103819357B (zh) * 2014-01-28 2016-03-16 浙江大学 (-)-有效霉醇叠氮四乙酸酯的制备方法
US9950989B2 (en) 2014-02-14 2018-04-24 Toa Eiyo Ltd. Cyclic hydrocarbon compound
CN107072976A (zh) 2014-05-12 2017-08-18 葛兰素史克知识产权第二有限公司 用于治疗传染性疾病的包含Danirixin的药物组合物
US9392814B2 (en) 2014-06-06 2016-07-19 Nicholas J. Singer Delivery system for drinks
GB2532178A (en) * 2014-06-09 2016-05-18 Redx Pharma Plc Antiviral compounds
CN118286245A (zh) 2014-12-26 2024-07-05 埃莫里大学 N4-羟基胞苷和衍生物及与其相关的抗病毒用途
USD773313S1 (en) 2015-06-23 2016-12-06 Nicholas J. Singer Package
US10676428B2 (en) 2015-12-17 2020-06-09 Ramot At Tel-Aviv University Ltd. Antiviral agents for amantadine-resistant influenza A
KR102339817B1 (ko) 2016-06-30 2021-12-16 한미약품 주식회사 오셀타미비어 함유 경구용 고형제제 및 그 제조방법
CR20190123A (es) * 2016-08-10 2019-04-30 Shionogi & Co Composiciones farmacéuticas que contienen derivados de piridona policíclicos sustituídos y profármacos de los mismos
US11331331B2 (en) 2017-12-07 2022-05-17 Emory University N4-hydroxycytidine and derivatives and anti-viral uses related thereto
KR20200106607A (ko) 2019-03-05 2020-09-15 주식회사 코아팜바이오 오셀타미비르 함유 의약 조성물

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968788A (en) * 1986-04-04 1990-11-06 Board Of Regents, The University Of Texas System Biologically reversible phosphate and phosphonate protective gruops
US5206400A (en) * 1986-07-07 1993-04-27 Ohio State University Diastereomeric mono- and di-substituted diamino cyclohexane compounds and the method of preparation thereof
AU2947889A (en) * 1988-01-12 1989-08-11 Board Of Regents, The University Of Texas System Histamine release inhibitory factor and preparations therefore
US5175273A (en) * 1988-07-01 1992-12-29 Genentech, Inc. Nucleic acid intercalating agents
US5270340A (en) * 1988-12-27 1993-12-14 Bayer Aktiengesellschaft Substituted 2-cyclohexen-1-yl-amine fungicidal and herbicidal agents
GB2238049A (en) * 1989-11-22 1991-05-22 Ki Nii Epidemiologii I Infekts Method for preparing inhibitor for influenza virus neuraminidase
AP249A (en) * 1990-04-24 1993-03-17 Biota Scient Management Pty Ltd Anti-viral compounds.
WO1992006691A1 (en) * 1990-10-19 1992-04-30 Biota Scientific Management Pty. Ltd. Anti-viral compounds that bind the active site of influenza neuramidase and display in vivo activity against orthomyxovirus and paramyxovirus
DE4033415A1 (de) * 1990-10-20 1992-04-23 Bayer Ag Antimikrobielle mittel sowie substituierte 2-cyclohexan-1-yl-amin-derivate und deren herstellung
DE4131311A1 (de) * 1991-09-20 1993-04-01 Basf Ag Dihydropyranderivate und diese enthaltende pflanzenschutzmittel
AU659501B2 (en) * 1991-10-23 1995-05-18 Biota Scientific Management Pty Ltd Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid
GB9126725D0 (en) * 1991-12-17 1992-02-12 Glaxo Group Ltd Process
FR2687674B1 (fr) * 1992-02-07 1995-05-19 Roussel Uclaf Nouveaux derives de la pyridone, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
US5292938A (en) * 1992-04-13 1994-03-08 Associated Universities, Inc. Synthesis of 4-substituted-trans-1, 2-diaminocyclohexyl polyaminocarboxylate metal chelating agents for the preparation of stable radiometal antibody immunoconjugates for therapy and spect and pet imaging
US5633360A (en) 1992-04-14 1997-05-27 Gilead Sciences, Inc. Oligonucleotide analogs capable of passive cell membrane permeation
GB9220327D0 (en) * 1992-09-25 1992-11-11 Glaxo Group Ltd Process
GB9220241D0 (en) * 1992-09-25 1992-11-11 Glaxo Group Ltd Process
US5639786A (en) * 1992-12-04 1997-06-17 Biota Scientific Management, Pty., Ltd. Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of α-D-neuraninic acid
US5514798A (en) * 1993-06-02 1996-05-07 Gilead Sciences, Inc. Method and cyclic carbonates for nucleotide analogues
US5819730A (en) * 1993-06-09 1998-10-13 Glaxo Wellcome Australia Ltd. Device for administering pharmaceutical substances
GB9311873D0 (en) * 1993-06-09 1993-07-28 Glaxo Group Ltd Process
GB9312531D0 (en) * 1993-06-17 1993-08-04 Glaxo Group Ltd Process
GB9325841D0 (en) * 1993-12-17 1994-02-23 Glaxo Group Ltd Chemical compounds
GB9400206D0 (en) * 1994-01-07 1994-03-02 Glaxo Group Ltd Chemical compound
AUPM354694A0 (en) * 1994-01-27 1994-02-17 Biota Scientific Management Pty Ltd Chemical compounds
US5985859A (en) * 1994-04-14 1999-11-16 The University Of Alabama Methods of inhibiting bacterial sialidase
GB9410817D0 (en) * 1994-05-28 1994-07-20 Glaxo Group Ltd Medicaments
AUPM725794A0 (en) * 1994-08-03 1994-08-25 Biota Scientific Management Pty Ltd Chemical compounds
US5556963A (en) * 1994-08-05 1996-09-17 Oklahoma Medical Research Foundation Synthesis of 4-alkoxy-N-acetylneuraminic acid
GB9416365D0 (en) * 1994-08-12 1994-10-05 Glaxo Group Ltd Medicaments
US5512596A (en) * 1994-09-02 1996-04-30 Gilead Sciences, Inc. Aromatic compounds
WO1996014314A2 (en) 1994-11-04 1996-05-17 Gilead Sciences, Inc. Thiepane compounds inhibiting and detecting hiv protease
US5866601A (en) * 1995-02-27 1999-02-02 Gilead Sciences, Inc. Carbocyclic compounds
SI9620042A (sl) * 1995-02-27 1998-12-31 Gilead Sciences, Inc. Novi selektivni inhibitorji virusnih ali bakterijskih neuraminidaz
US5602277A (en) 1995-03-30 1997-02-11 Biocryst Pharmaceuticals, Inc. Substituted benzene derivatives useful as neuraminidase inhibitors
US5714509A (en) 1995-05-03 1998-02-03 The University Of Alabama Inhibitors of bacterial sialidase and methods of making and using the same
GB9525389D0 (en) 1995-12-12 1996-02-14 Biota Scient Management Ltd Chemical compounds
GB9510141D0 (en) 1995-05-19 1995-07-12 Biota Scient Management Chemical compounds
JP4162712B2 (ja) * 1995-05-19 2008-10-08 バイオタ、サイアンティフィック、マネージメント、プロプライエタリ、リミテッド ６−カルボキサミドジヒドロピラン誘導体
GB9516276D0 (en) * 1995-08-08 1995-10-11 Biota Scient Management Chemical compounds
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
JP3622983B2 (ja) 1996-08-23 2005-02-23 ギリアード サイエンシーズ， インコーポレイテッド シクロヘキセンカルボキシレート誘導体の調製
US5859284A (en) 1996-08-23 1999-01-12 Gilead Sciences, Inc. Preparation of carbocyclic compounds
AU711845B2 (en) * 1996-09-10 1999-10-21 Daikin Industries, Ltd. 4-substituted-2,7-dideoxy-7-fluoro-2,3-didehydro-sialic acid compounds
US5886213A (en) 1997-08-22 1999-03-23 Gilead Sciences, Inc. Preparation of carbocyclic compounds

Similar Documents

Publication Publication Date Title
JP2002161074A5 (enExample)
RU2470016C2 (ru) Производное бипиразола
JP2019218375A5 (enExample)
JP2004503248A5 (enExample)
JP2009511595A5 (enExample)
JP2009526751A5 (enExample)
JP2008526757A5 (enExample)
BR0309546A (pt) Composto, composição farmacêutica que compreende o mesmo, processo para a sua preparação e utilização e método para tratamento profilático ou terapêutico de diabetes do tipo ii
JP2002540208A5 (enExample)
JP2002501049A5 (enExample)
FI3300743T3 (fi) Menetelmiä rokotteen antamiseksi
JP2002509153A5 (enExample)
RU95113474A (ru) Применение 2-амино-6-н-пропиламино-4,5,6,7-тетрагидробензотиазола, его энантиомеров и фармакологически переносимых кислотноаддитивных солей в качестве антидепрессанта и фармацевтическая композиция с антидепрессивной активностью на их основе
EP1116711A3 (de) 2-Aminoalkyl-1,4-diaminobenzol-Derivate und diese Verbindungen enthaltende Färbemittel
CA2399368A1 (en) Fluorescent detection method and reagent
BR0114196A (pt) Formas polimórficas de maleato de 5-[4-[2-[n-metil-n-(2-piridil) amino]etóxi]benzil]tiazolidina-2,4-diona e processo para a preparação das mesmas.
JP2004502684A5 (enExample)
JP2003507721A5 (enExample)
JP2005513036A5 (enExample)
FR2967576B1 (fr) Composition pharmaceutique comprenant du sel precurseur du cycle de krebs, en particulier du sel de citrate, et son utilisation comme medicament
BR112012021532B1 (pt) Composição para tratamento de unhas com fungo
JP2004510749A5 (enExample)
BR0009077A (pt) Antìgenos de tuberculose e métodos de uso dos mesmos
CN1059910A (zh) 一种用dna探针检测病原体的新方法
EP0948967A3 (en) Treatment of viral disease in swine